You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Estrogen Receptor

Showing 26 - 50 of 8,856
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Chuo-Ku, Kashiwa-Shi, Nagoya-Shi (Amcenestrant (SAR439859))

Active, not recruiting
  • Breast Cancer
  • Amcenestrant (SAR439859)
  • Chuo-Ku, Japan
  • +2 more
Nov 16, 2022

Breast Cancer Trial ([68Ga]Ga-NeoB, [177Lu]Lu-NeoB, Ribociclib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
May 22, 2023

Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago

Not yet recruiting
  • Estrogen-receptor-positive Breast Cancer
  • +3 more
  • elacestrant, palbociclib, abemaciclib, ribociclib
  • Chicago, Illinois
    Northwestern University
Sep 25, 2023

Breast Cancer Trial in Shanghai (ARV-471)

Not yet recruiting
  • Breast Cancer
  • Shanghai, China
    Cancer Hospital Chinese Academy of Medical Sciences
Feb 7, 2023

Electronic Medical Record-Based Nudge to Reduce SLNB

Recruiting
  • Breast Cancer
  • Estrogen-receptor-positive Breast Cancer
  • Column-based nudge in the EHR
  • No column-based nudge in the EHR
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Aug 17, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Prognostic Stage IV Breast Cancer AJCC v8
  • Pembrolizumab
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 5, 2023

Breast Cancer, Estrogen Receptor-positive Breast Cancer Trial in Charlottesville (Aspirin, Tamoxifen Pill, Doxorubicin)

Withdrawn
  • Breast Cancer
  • Estrogen Receptor-positive Breast Cancer
  • Charlottesville, Virginia
    University of Virginia
Nov 12, 2021

Estrogen Receptor Positive Breast Cancer, Breast Tumor, Metastatic Breast Cancer Trial in Philadelphia ([18F]FES)

Active, not recruiting
  • Estrogen Receptor Positive Breast Cancer
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Jul 5, 2022

Breast Cancer Trial in Denver, Sarasota, Nashville (AC682)

Recruiting
  • Breast Cancer
  • Denver, Colorado
  • +4 more
Dec 12, 2022

Assessed by 18F-FES PET/CT in MBC With ER-positive Primary Tumor

Recruiting
  • Breast Cancer
    • Shanghai, Shanghai, China
      Biyun Wang, MD
    Apr 5, 2023

    Healthy Trial in Austin ([phenyl-14C]ARV-471, [oxoisoindolin-14C]ARV-471)

    Recruiting
    • Healthy
    • Austin, Texas
      PPD Phase I Clinic
    Jun 29, 2023

    Estrogen Receptor-Positive Breast Carcinoma Trial in Rochester (dietary supplement, drug, other)

    Not yet recruiting
    • Estrogen Receptor-Positive Breast Carcinoma
    • Mushroom
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 31, 2023

    Metastatic Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 Trial in United States (drug, other, biological)

    Suspended
    • Metastatic Breast Carcinoma
    • Stage IV Breast Cancer AJCC v6 and v7
    • Corona, California
    • +6 more
    Sep 28, 2022

    Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Miami, Florida
      University of Miami
    Apr 12, 2023

    Recurrence Score on Adjuvant Treatment Decisions in Breast

    Recruiting
    • Breast Cancer Female
      • Tübingen, BW, Germany
        Department for Women's Health
      Nov 4, 2022

      Breast Tumors Trial in Wuhu Shi, Changsha, Shanghai (LY3484356)

      Not yet recruiting
      • Breast Neoplasms
      • Wuhu Shi, Anhui, China
      • +2 more
      Aug 19, 2022

      Healthy Participants Trial in Brussels (Vepdegestrant, Carbamazepine)

      Not yet recruiting
      • Healthy Participants
      • Brussels, Belgium
        Pfizer Clinical Research Unit - Brussels
      Aug 15, 2023

      Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Houston (Radiation Therapy, Therapeutic

      Active, not recruiting
      • Estrogen Receptor Positive
      • +3 more
      • Radiation Therapy
      • Therapeutic Conventional Surgery
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 14, 2022

      FDG PET/CT in Breast Cancer Bone Mets

      Active, not recruiting
      • Estrogen Receptor Positive Breast Cancer
      • Bone Metastases
      • FDG PET/CT scan
      • Philadelphia, Pennsylvania
        University of Pennsylvania Hospital
      Oct 13, 2022

      Frequency in Fibromyalgia Syndrome

      Completed
      • Fibromyalgia
      • ACR 1990 fibromyalgia critters
      • Niğde, Turkey
        BOR Physical medicine and rehabilitaton hospital
      Aug 31, 2021

      Healthy Trial (ARV-471, Dabigatran etexilate)

      Not yet recruiting
      • Healthy
      • (no location specified)
      Dec 21, 2022

      Breast Cancer Trial in Phoenix, Zion, Nashville (Elacestrant, Onapristone)

      Recruiting
      • Breast Cancer
      • Phoenix, Arizona
      • +2 more
      Jan 20, 2023

      Detection and Analysis of MBC With Heterogeneous ER Expression

      Active, not recruiting
      • Breast Cancer
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        May 30, 2022

        Breast Tumors, Breast Cancer, Estrogen-receptor Positive Breast Cancer Trial in France, United Kingdom, United States (H3B-6545)

        Active, not recruiting
        • Breast Neoplasms
        • +7 more
        • Goodyear, Arizona
        • +38 more
        Jun 29, 2022

        Breast Cancer, Estrogen Receptor Positive Tumor, HER2-negative Breast Cancer Trial in Seoul (Ovarian function suppression with

        Not yet recruiting
        • Breast Cancer
        • +4 more
        • Ovarian function suppression with endocrine treatments
        • Seoul, Korea, Korea, Republic of
          Gangnam Severance Hospital
        Dec 18, 2022